This article is more than 5 years old. Information may no longer be current.
Society for Translational Oncology presents Pinedo Prize
Click Here to Manage Email Alerts
The Society for Translational Oncology presented its 2015 Bob Pinedo Cancer Care Prize to Richard M. Goldberg, MD, a gastrointestinal oncologist and physician-in-chief at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The $50,000 award recognizes Goldberg’s clinical and research leadership in gastrointestinal cancers, as well as his compassionate care of patients with cancer.
Richard M. Goldberg
Goldberg’s clinical interests include colorectal and other gastrointestinal (GI) cancers, carcinoid and GI tract neuroendocrine tumors, new drug development and inherited predisposition to GI cancers.
Goldberg has led a national intergroup study N9741 as part of an international phase 3 study of oxaliplatin, irinotecan and 5-fluorouracil in combinations for first-line treatment of advanced colorectal cancer. The study led to the approval of oxaliplatin for clinical use.
“I am delighted that Dr. Richard Goldberg is this year’s Pinedo Prize recipient. He is an outstanding clinician and cancer researcher whose work, particularly in gastrointestinal cancers, has benefitted patients across the world,” Professor Patrick G. Johnston, co-chair of the Society for Translational Oncology, said in a press release.